Hypertension in adolescents is an increasingly recognized condition and is associated with both current target-organ injury and future adult cardiovascular risk. In adolescents, primary hypertension is now the predominant form of hypertension, particularly in those with obesity, excess adiposity, family history of hypertension, and other cardiometabolic risk factors. Accurate blood pressure measurement, confirmation of persistent elevation, and appropriate evaluation for secondary causes and target-organ damage are essential because childhood and adolescent hypertension often tracks into adulthood.
The pathophysiology of hypertension can be either primary, which is multifactorial, or secondary, in which hypertension develops as a consequence of other diseases.
Hypertension in adolescents may be a symptom of other underlying and undiagnosed conditions. Thus, these patients require a detailed medical assessment. Secondary causes were discussed above and include: renal diseases, drugs, adrenal diseases and hyperthyroidism.
According to the WHO, an estimated 1.13 billion people worldwide have hypertension.
Hypertension commonly affects individuals older than 65 years of age, especially living in low or middle-income countries.
In a study from the University of Texas' McGovern Medical School, the prevalence of pediatric elevated hypertension from 10 to 17 years of age was 16.3%, stage 1 hypertension was 10.6% and stage 2 hypertension 2.4%.[9]
Higher prevalence was noted in patients who were classified as obese or overweight.[9]
Prevalence of childhood hypertension has increased from 1994 to 2018.[10]
The U.S. Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for high blood pressure in asymptomatic children and adolescents aged 3 to 18 years.[11]
The 2017 American Academy of Pediatrics guideline recommends measuring blood pressure annually beginning at 3 years of age and at every health care encounter in children and adolescents with obesity, kidney disease, diabetes, a history of aortic arch obstruction or coarctation, or use of medications known to increase blood pressure.[1]
According to the 2016 European Society of Hypertension guidelines, screening for hypertension in asymptomatic children and adolescents is recommended every two years beginning at three years of age.[12]
Hypertension in adolescents should be suspected on the basis of properly performed office blood pressure measurements and confirmed with ambulatory blood pressure monitoring when indicated.[14]
Office blood pressure should be measured in the right arm with an appropriately sized cuff after the patient has been seated quietly, and elevated oscillometric readings should be confirmed by auscultation.[1][11]
Ambulatory blood pressure monitoring is recommended to confirm hypertension in children and adolescents with persistent elevated office readings or stage 1 hypertension across repeated visits, and it is particularly useful for identifying white-coat hypertension, masked hypertension, and abnormal nocturnal blood pressure patterns.[1][15]
The history should assess birth history, growth, renal and urologic disease, sleep-disordered breathing, medication and substance exposures, diet and physical activity, and family history of hypertension, kidney disease, and premature cardiovascular disease.[1]
The physical examination should include height, weight, body mass index, repeat blood pressure measurement with correct cuff size, pulse examination, and focused assessment for coarctation of the aorta, endocrine disease, and other secondary causes.[1]
The physical examination should include height, weight, body mass index, repeat blood pressure measurement with correct cuff size, pulse examination, and focused assessment for coarctation of the aorta, endocrine disease, and other secondary causes.[1]
There are no laboratory tests that by themselves diagnose hypertension.[1]
Initial evaluation commonly includes urinalysis, serum electrolytes, blood urea nitrogen, creatinine, and a lipid profile.[1]
In adolescents with obesity, additional evaluation for cardiometabolic comorbidity should include screening for abnormal glucose metabolism and liver disease.[1]
Renin, aldosterone, thyroid testing, drug screening, sleep evaluation, and other specialized tests should be obtained selectively when the history, physical examination, age, or severity of hypertension suggests a secondary cause.[1]
Renal ultrasonography is recommended in younger children and in those with abnormal urinalysis, impaired renal function, or suspicion for renovascular or structural renal disease.[1]
Electrocardiography is not recommended as the primary method to assess left ventricular hypertrophy in pediatric hypertension because of limited sensitivity.[1]
Echocardiography is not diagnostic of hypertension, but it is useful for evaluation of hypertension-mediated target-organ damage, particularly left ventricular hypertrophy, and should be considered when pharmacologic therapy is being considered.[1]
Repeat echocardiography may be used selectively to monitor persistent hypertension or previously documented target-organ injury.[1]
CT or MRI is not used to diagnose hypertension itself but may be used selectively to evaluate suspected secondary causes such as coarctation of the aorta, renovascular disease, or adrenal pathology.[1]
The AAP guideline recommends keeping systolic and diastolic pressure under 90th percentile or <130/80 mmHg in patients aged 13 or older to prevent any cardiovascular events.
All children and adolescents with hypertension should change their lifestyle for the better.[12]
Such changes include: weight reduction if obese or overweight, regular physical activity, healthy diet (DASH diet), avoidance of substance use, stress reduction, family-based interventions (involving the whole family on such lifestyle changes can dramatically increase therapeutic adherence).[12]
Lifestyle modification is the foundation of treatment for adolescents with elevated blood pressure or hypertension, especially in primary hypertension associated with excess adiposity and other cardiometabolic risk factor.[1]
Recommended nonpharmacologic therapy includes weight reduction when indicated, regular physical activity, a healthy dietary pattern such as the DASH diet, sodium reduction, sleep optimization, and avoidance of tobacco, alcohol, and other substances that can increase blood pressure.[1][16][14]
Pharmacologic therapy is indicated for adolescents with symptomatic hypertension, stage 2 hypertension without a clearly modifiable factor, persistent hypertension despite lifestyle intervention, or hypertension associated with chronic kidney disease or diabetes.[1]
Recommended first-line antihypertensive agents include angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, long-acting calcium channel blockers, and thiazide diuretics.[1]
Antihypertensive medication should generally be started at a low dose and titrated every 2 to 4 weeks until the blood pressure goal is achieved or dose-limiting adverse effects occur.[1]
Start at the lowest dose and titrate every 2 to 4 weeks until blood pressure goal is reached.[12]
Home blood pressure monitoring may be a useful adjunct in follow-up, but ambulatory blood pressure monitoring remains the preferred out-of-office method for confirming hypertension and distinguishing white-coat from masked hypertension in children and adolescents.[1][15][14]
Effective measures for the primary prevention of primary hypertension in children include low sodium intake, adhering to the DASH diet, maintaining appropriate body weight, and regular physical activities.
After diagnosis, secondary prevention focuses on sustained blood pressure control, treatment adherence, repeated assessment for target-organ damage when indicated, and management of associated cardiovascular risk factors such as obesity, dyslipidemia, diabetes, and sleep-disordered breathing.[1]
↑Khoury M, Urbina EM (2021). "Hypertension in adolescents: diagnosis, treatment, and implications". Lancet Child Adolesc Health. 5 (5): 357–366. doi:10.1016/S2352-4642(20)30344-8.
↑Friedman K, Wallis T, Maloney KW; et al. (2007). "An unusual cause of pediatric hypertension". J Pediatr. 151: 206.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
↑Marcus CL, Greene MG, Carroll JL (1998). "Blood pressure in children with obstructive sleep apnea". Am J Respir Crit Care Med. 157: 1098.CS1 maint: Multiple names: authors list (link)
↑ 14.014.114.2Falkner B, Gidding SS, Baker-Smith CM; et al. (2023). "Pediatric Primary Hypertension: An Underrecognized Condition: A Scientific Statement From the American Heart Association". Hypertension. 80 (6): e101–e111. doi:10.1161/HYP.0000000000000228.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
↑ 15.015.1Flynn JT, Urbina EM, Brady TM; et al. (2022). "Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association". Hypertension. 79 (7): e114–e124. doi:10.1161/HYP.0000000000000215.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
↑Lurbe E, Wühl E; et al. (2023). "Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 2. How to manage high blood pressure in children and adolescents". Front Pediatr. 11: 1140617. doi:10.3389/fped.2023.1140617.CS1 maint: Explicit use of et al. (link)